Care

Introducing a hepatitis C outreach and treatment program in Australian community pharmacies, particularly those offering opioid agonist therapy, could significantly increase testing, diagnosis, and cure of those living with the virus. More

In 2023, Egypt became the first country to fulfill the World Health Organization’s set programmatic criteria of reduction of hepatitis C incidence and mortalities to levels close to elimination of disease. More

A study developed an agent-based model to characterize the HCV epidemic in Canada, a resource-rich country with ongoing immigration from HCV-endemic regions, relying exclusively on risk-based screening for case identification. More

A case study, published in MMVR, explored Georgia’s efforts and progress toward hepatitis B and hepatitis C elimination. More

A study, published in Drugs - Real World Outcomes, quantified the incidence of cancer in patients treated with HCV therapies in Catalonia, Spain and their matched controls. More

In a policy brief, WHO gives an update on the parts of the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care relevant for men who have sex with men. More

A study evaluates vertical transmission and linkage to care in women with HCV and history of injection drug use employing co-localized testing and treatment. More

Drawing on interviews with people with lived experience of hepatitis C, an article considers how affected people feel about complaints processes and the act of complaining in Australia. More

Acceptability of HCV screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine: A cross-sectional survey More

Findings from a study suggest that OAT programs are ideally positioned to reach people who previously injected or currently inject drugs to engage them in hepatitis C testing and treatment. More